| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 48.12.08 Anticholinergic Agents (Respiratory) | No observations |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 48.12.08 Anticholinergic Agents (Respiratory) | No observations |